Science AI Journal
Medicine · Research topic

Open research questions in Inflammatory mediators and NSAID effects

92 unresolved questions extracted from the limitations and future-work sections of 267 Inflammatory mediators and NSAID effects papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • The study requires confirmation in larger, independent studies before the clinical relevance can be established, - The study had a limited sample size, - The study only investigated the association between genetic polymorphisms and postoperative pain in patients receiving preoperative ibuprofen or diclofenac

    Association of genetic polymorphisms with response to preoperative NSAIDs in endodontic postoperative pain: a randomized double-blind placebo-controlled clinical trial · 2026 · DOI

  • The response to NSAIDs may depend on individual biological differences, including genetic factors. Genetic factors influencing drug metabolism have been recognized as major determinants of interindividual variability in analgesic response.

    Association of genetic polymorphisms with response to preoperative NSAIDs in endodontic postoperative pain: a randomized double-blind placebo-controlled clinical trial · 2026 · DOI

  • The need for large-scale trials to validate the long-term safety and biomarker-driven accuracy of celecoxib. The necessity for an individualized approach to therapy, depending on COX-2 expression and estrogen receptor status. The requirement for further research on the effects of celecoxib in different cancer types and subtypes.

    Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy · 2025 · DOI

  • The study identifies the challenge of managing diabetes mellitus and osteoarthritis simultaneously. There is a need to develop effective therapeutic strategies for managing both DM and OA comorbidities. The research highlights the challenge of understanding the complex pathophysiological links between diabetes and osteoarthritis.

    Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions · 2024 · DOI

  • The study identifies a gap in the understanding of the link between diabetes and osteoarthritis. There is a need for further research on the effects of insulin, metformin, and GLP-1-based therapies on OA outcomes. The current understanding of the pathophysiological links between diabetes and osteoarthritis is limited.

    Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions · 2024 · DOI

  • However, their usage patterns and associated risk factors in the general population remain insufficiently understood, particularly in the Iranian context.

    A study of demographic and clinical characteristics of consumers of non-steroidal anti-inflammatory drugs: a large population-based study utilizing enrollment phase data from the tabari cohort · 2025 · DOI

  • Despite the breakthrough of celecoxib in the field of oncology treatment, large-scale trials are warranted to validate its long-term safety and biomarker-driven accuracy.

    Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy · 2025 · DOI

  • Further research into the molecular mechanisms regulating Prg4 expression will be essential in developing more effective OA treatments.

    Prg4 and Osteoarthritis: Functions, Regulatory Factors, and Treatment Strategies · 2025 · DOI

  • While artemisinin (ART), a key active compound from the traditional Chinese medicinal herb Artemisia annua, has been recognized for its antiproliferative activity against colon cancer cells, its underlying molecular underpinnings remain elusive.

    Discovery of Artemisinins as Microsomal Prostaglandins Synthase-2 Inhibitors for the Treatment of Colorectal Cancer via Chemoproteomics · 2024 · DOI

  • In conclusion, these benzimidazole derivatives warrant further exploration into new and alternative analogs, potentially uncovering novel compounds with a favorable pharmacological profile possessing significant anti-inflammatory and analgesic properties.

    Novel Benzimidazole Derivatives as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase 1 for the Potential Treatment of Inflammation, Pain, and Fever · 2024 · DOI

  • The risk of serious bleeding events associated with aspirin usage. The potential for aspirin to promote cancer in certain scenarios. The need for a thorough risk-benefit analysis and customized dose regimens before routinely prescribing aspirin usage for cancer prevention.

    Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence · 2026 · DOI

  • The paper identifies a gap in the current understanding of aspirin's role in cancer, particularly in terms of its potential to promote cancer in certain scenarios. The paper also notes that the findings in older groups are variable, with some research suggesting no mortality benefit and even a potential rise in late-stage cancer deaths.

    Aspirin's Dual Role in Cancer: A Systematic Review of the Current Evidence · 2026 · DOI

  • Further development of indole-based COX-2 inhibitors with acceptable drug-like characteristics is a future research direction. The integration of structural, pharmacokinetic, and systems-level data can facilitate the rational innovation of novel scaffolds or hybrid molecules.

    DESIGN AND SYNTHESIS OF INDOLE DERIVATIVES AS COX-2 INHIBITORS FOR ANTI- INFLAMMATORY ACTIVITY · 2026 · DOI

  • The development of COX-2 selective inhibitors with minimal adverse effects is a research gap. The emergence of off-target toxicities and incomplete selectivity are challenges in the development of indole-based COX-2 inhibitors.

    DESIGN AND SYNTHESIS OF INDOLE DERIVATIVES AS COX-2 INHIBITORS FOR ANTI- INFLAMMATORY ACTIVITY · 2026 · DOI

  • Clinical translation still faces considerable difficulties. Radiotracers suffer from poor in vivo stability and targeting. Non-specific binding remains a challenge.

    A comprehensive review of 11C-, 18F-, and 123/124/125I-labeled radiotracers targeting cyclooxygenase-2 over the past two decades · 2026 · DOI

  • Ongoing efforts in structural optimization. The development of advanced COX-2-expressing transgenic models. The exploration of new radioactive isotopes for labeling COX-2 inhibitors.

    A comprehensive review of 11C-, 18F-, and 123/124/125I-labeled radiotracers targeting cyclooxygenase-2 over the past two decades · 2026 · DOI

  • There is a need to explore the anti-inflammatory potential of Convolvulus oxyphyllus extracts. There is a need to elucidate the mechanisms of action of the extracts.

    Biogenic selenium extract-mediated and total Convolvulus oxyphyllus extracts suppress IL6 and COX2 expression: insights from LC–MS metabolite profiling and molecular docking · 2026 · DOI

  • There is a need to investigate the anti-inflammatory activity of Cassipourol and β-sitosterol from Malva parviflora L. There is a need to identify potential targets for the compounds.

    Cassipourol and β-sitosterol from Malva parviflora L.: a mechanistic study of dual anti-inflammatory action against COX/LOX and TNF-α/BCL-2 · 2026 · DOI

  • The development of novel and more efficient strategies for cancer treatment is essential. There is a need to explore new pharmacological approaches for cancer treatment.

    INVESTIGATION OF THE CYTOTOXIC AND GENOTOXIC EFFECTS OF PAROXETINE ON HUMAN OVARIAN, PROSTATE AND COLON CANCER CELL LINES · 2026 · DOI

  • Limited understanding of the biotransformation pathways of NSAIDs by microorganisms. Difficulty in evaluating the toxicity of biotransformation products. Need for standardized methods for ecotoxicity evaluation of biotransformation products.

    Biotransformation of common NSAIDs by Cunninghamella species and resulting metabolite toxicity · 2026 · DOI

  • Limited knowledge on the biotransformation of NSAIDs by microorganisms. Lack of understanding on the toxicity of biotransformation products. Need for alternative strategies to reduce the environmental toxicity of NSAIDs.

    Biotransformation of common NSAIDs by Cunninghamella species and resulting metabolite toxicity · 2026 · DOI

  • There is a lack of comprehensive evidence regarding the anti-inflammatory mechanism of Fagonia cretica. The study aims to fill this gap by evaluating the phytochemical, anti-inflammatory, and toxicological profiles of EEFC.

    Mechanistic insight into anti-inflammatory activity of Fagonia cretica via COX inhibition and multimodal pharmacological evaluation · 2026 · DOI

  • Oral mucositis is a debilitating inflammatory condition. The pathophysiology of oral mucositis involves complex inflammatory signaling pathways. There is a need for novel therapeutic strategies to address oral mucositis.

    Anti-inflammatory Potential of Apigenin and Luteolin in Oral Mucositis: An In Silico Docking Study Targeting IL-6, NF-κB, and COX-2 · 2026 · DOI

  • Further in vitro and in vivo investigations are required to determine the therapeutic effects of apigenin and luteolin. The study suggests the need for additional research on the potential of natural flavonoids as anti-inflammatory agents.

    Anti-inflammatory Potential of Apigenin and Luteolin in Oral Mucositis: An In Silico Docking Study Targeting IL-6, NF-κB, and COX-2 · 2026 · DOI

  • Further investigation into the safety and efficacy of quinoline derivatives, - The development of new quinoline-based anti-inflammatory agents, - The examination of the therapeutic potential of quinoline derivatives in various diseases.

    Therapeutic Evolution of Quinoline Scaffold: Natural Alkaloids to Next Generation Anti-Inflammatory Pleiotropic Modulators · 2026 · DOI

Most-cited papers in Inflammatory mediators and NSAID effects

Most recent work

Find a gap in your own Inflammatory mediators and NSAID effects sub-topic

This page shows what the Inflammatory mediators and NSAID effects literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 4.5M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
2,404 open questions
Substance Abuse Treatment and Outcomes
2,046 open questions
Dementia and Cognitive Impairment Research
1,148 open questions
Smoking Behavior and Cessation
1,056 open questions
Innovations in Medical Education
1,015 open questions
Physical Activity and Health
1,010 open questions
Attention Deficit Hyperactivity Disorder
970 open questions
Schizophrenia research and treatment
962 open questions
92 open questions have been extracted from the limitations and future-work passages of 267 Inflammatory mediators and NSAID effects papers in our 4.5M-paper local library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.